Back

Assessment of diastolic dysfunction in cancer patients with chemotherapy

20 June 2025 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Stratification, Prevention and Monitoring CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Ana Karen Garro Almendaro

ISSSTE 20 DE NOVIEMBRE, Ciudad de Mexico (Mexico)

64 More presentations in this session

Presentation thumbnail
Reference values of strain-derived myocardial work indices in adult cancer survivors: results from an observational study and comparison with data from the EACVI NORRE population.
Doctor L. Amore (Rome, IT)
Abstract Slides
Presentation thumbnail
Comparative characteristics of anticoagulants used in cancer-associated thrombosis
Doctor V. Petrusheva (Pleven, BG)
Abstract Slides
Presentation thumbnail
Stroke and cancer - investigating the prevalence of fear among the polish population. cross-sectional study.
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
High-sensitivity troponin T as a biomarker of exercise tolerance impairment assessed in CPET and left ventricular function 3 months after adjuvant therapy for breast cancer
Professor A. Bielecka-Dabrowa (Lodz, PL)
Abstract Slides
Presentation thumbnail
Ibrutinib increases major adverse cardiovascular events through initiation and exacerbation of hypertension
Assistant Professor Y. Chan (Hong Kong, HK)
Abstract Slides

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

ESC Cardio-Oncology 2025

20 June 2025 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Association of endothelin-1 levels and left ventricular diastolic function parameters in patients with lymphomas 12 months after polychemotherapy
thumbnail
Congress Presentation
The ability of the conventional echocardiographic parameters to detect early right ventricular impairment during cancer therapy
thumbnail
Congress Presentation
Echocardiographic changes in the right ventricle during chemotherapy - a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources